Widget Image
Follow PPD Social Media
Saturday, November 2, 2024
HomeNewsPoliticsSenator John McCain Returning to Arizona Before Tax Reform Vote

Senator John McCain Returning to Arizona Before Tax Reform Vote

Sen. John McCain of Arizona speaking with reporters at the Capitol in Washington on Thursday. (Photo: Reuters)
Sen. John McCain of Arizona speaking with reporters at the Capitol in Washington on Thursday. (Photo: Reuters)

Sen. John McCain of Arizona speaking with reporters at the Capitol in Washington on Thursday. (Photo: Reuters)

Sen. John McCain is reportedly returning home to Arizona to recover from the side effects of chemotherapy for a brain tumor and will miss the tax reform vote this week, two sources confirmed to CNN. He is unlikely to return to Washington before the New Year and it is not expected he will be needed to pass the bill.

“Thank you to everyone for their kind words. My father is doing well and we are all looking forward to spending Christmas together in Arizona,” she tweeted Sunday afternoon.

The Arizona senator was admitted into Walter Reed Medical Center on Wednesday after missing a third straight day of votes in the Senate. Republican sources told CNN he was “exhausted, but ok.” He was diagnosed with a type of brain tumor called a glioblastoma following surgery to remove a blood clot in July.

A vote is expected first in the U.S. House of Representatives and then the U.S. Senate early this week. Sen. Bob Corker, R-Tenn., announced on Friday that he would support the first overhaul to the U.S. tax code in 31 years. He did not support the bill during the first vote.

Written by

People's Pundit Daily delivers reader-funded data journalism covering the latest news in politics, polls, elections, business, the economy and markets.

Latest comments

leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

People's Pundit Daily
You have %%pigeonMeterAvailable%% free %%pigeonCopyPage%% remaining this month. Get unlimited access and support reader-funded, independent data journalism.

Start a 14-day free trial now. Pay later!

Start Trial